(Q37386240)

20 August 2017

Asian trends in primary androgen depletion therapy on prostate cancer (English)

1 reference

20 August 2017

1 reference

Hideyuki Akaza

1

1 reference

20 August 2017

1 December 2013

1 reference

Cancer Biology & Medicine

20 August 2017

1 reference

20 August 2017

10

1 reference

20 August 2017

4

1 reference

20 August 2017

187-191

1 reference

Intermittent versus continuous androgen deprivation in prostate cancer

20 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3860344

Intermittent androgen suppression for rising PSA level after radiotherapy

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3860344

Risk assessment among prostate cancer patients receiving primary androgen deprivation therapy

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3860344

Prostate cancer control--aims of the UICC Asia Regional Office Consortium.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3860344

Asian trends in prostate cancer hormone therapy

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3860344

Sixth joint meeting of J-CaP and CaPSURE--a multinational perspective on prostate cancer management and patient outcomes

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3860344

Fifth Joint Meeting of J-CaP and CaPSURE: advancing the global understanding of prostate cancer and its management

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3860344

Prostate Cancer Working Group Report

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3860344

Combined androgen blockade with bicalutamide for advanced prostate cancer: long-term follow-up of a phase 3, double-blind, randomized study for survival

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3860344

The 5th Conference on Asian Trends in Prostate Cancer Hormone Therapy.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3860344

The 3rd Conference on Asian Trends in Prostate Cancer Hormone Therapy

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3860344

The 2nd conference on Asian trends in prostate cancer hormone therapy

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3860344

Studies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. 1941.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3860344

Urological cancer. The benefits of intermittent androgen-deprivation therapy

2 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24349828

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Effects of intermittent androgen suppression on androgen-dependent tumors. Apoptosis and serum prostate-specific antigen

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24349828

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.7497/J.ISSN.2095-3941.2013.04.002

1 reference

20 August 2017

1 reference

PMC publication ID

3860344

20 August 2017

PubMed publication ID

24349828

1 reference

PMC publication ID

3860344